與「Simone Parisi」相符的使用者個人學術檔案

SIMONE PARISI

- 在 cittadellasalute.to.it 的電子郵件地址已通過驗證 - 被引用 2718 次

Simone Parisi

- 在 ualberta.ca 的電子郵件地址已通過驗證 - 被引用 713 次

The unsurprising effectiveness of pre-trained vision models for control

S Parisi, A Rajeswaran… - … on machine learning, 2022 - proceedings.mlr.press
Recent years have seen the emergence of pre-trained representations as a powerful abstraction
for AI applications in computer vision, natural language, and speech. However, policy …

Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study

…, E Bravi, G Barausse, R Bortolotti, C Selmi, S Parisi… - Medicine, 2015 - journals.lww.com
Anti Jo-1 antibodies are the main markers of the antisynthetase syndrome (ASSD), an
autoimmune disease clinically characterized by the occurrence of arthritis, myositis, and interstitial …

Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

…, N Perez Gomez, E Fusaro, S Parisi… - Journal of clinical …, 2019 - mdpi.com
Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

Viral arthritis and COVID-19

S Parisi, R Borrelli, S Bianchi, E Fusaro - The Lancet Rheumatology, 2020 - thelancet.com
The current outbreak of COVID19, caused by severe acute respiratory syndrome coronavirus
2 (SARSCoV2), is characterised by clinical signs and symptoms such as interstitial …

Interesting object, curious agent: Learning task-agnostic exploration

S Parisi, V Dean, D Pathak… - Advances in Neural …, 2021 - proceedings.neurips.cc
Common approaches for task-agnostic exploration learn tabula-rasa--the agent assumes
isolated environments and no prior knowledge or experience. However, in the real world, …

COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies

…, G Sambataro, A Fabiola, M Govoni, S Parisi… - Muscle & …, 2022 - Wiley Online Library
Introduction/Aims In this study we investigated COVID‐19 vaccination–related adverse
events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory myopathies (IIMs) …

Serum Jo-1 autoantibody and isolated arthritis in the antisynthetase syndrome: review of the literature and report of the experience of AENEAS collaborative group

…, G Barausse, R Bortolotti, C Selmi, S Parisi… - Clinical Reviews in …, 2017 - Springer
Anti-Jo-1 is the most frequently detectable antibody in the antisynthetase syndrome (ASSD),
an autoimmune disease characterized by the occurrence of arthritis, myositis, and interstitial …

Policy gradient approaches for multi-objective sequential decision making

S Parisi, M Pirotta, N Smacchia… - … Joint Conference on …, 2014 - ieeexplore.ieee.org
This paper investigates the use of policy gradient techniques to approximate the Pareto
frontier in Multi-Objective Markov Decision Processes (MOMDPs). Despite the popularity of …

Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study

…, G Rovera, F Sassi, MM Rigoni, C Lomater, S Parisi… - PLoS …, 2017 - journals.plos.org
The aim of this study was to evaluate differences in T helper cell sub-types and osteoclast (OCs)
precursors in peripheral blood between patients affected by early rheumatoid arthritis (…

Multi-objective reinforcement learning with continuous pareto frontier approximation

M Pirotta, S Parisi, M Restelli - Proceedings of the AAAI conference on …, 2015 - ojs.aaai.org
This paper is about learning a continuous approximation of the Pareto frontier in Multi-Objective
Markov Decision Problems (MOMDPs). We propose a policy-based approach that …